Borge O J, Rognum T O
Rettsmedisinsk institutt Rikshospitalet 0027 Oslo.
Tidsskr Nor Laegeforen. 2001 Jan 10;121(1):69-72.
Intracytoplasmic sperm injection (ICSI) is performed in a large number of fertility clinics; since 1991, several thousand children have been conceived by this method. Intracytoplasmic sperm injection is different than traditional in vitro-fertilization (IVF) in that a single spermatozoon is mechanically transferred into a mature oocyte using a glass pipette. Concern has been raised as to whether intracytoplasmic sperm injection damages the chromosomes and/or the spindle apparatus in the oocyte, leading to an increased risk of congenital abnormalities.
We have reviewed the literature on congenital abnormalities in children conceived by intracytoplasmatic sperm injection.
Although the reports are methodologically heterogeneous, most articles conclude that intracytoplasmatic sperm injection does not cause a statistically significant increased risk of congenital abnormalities compared to traditional in vitro fertilization or normally conceived children. However, some studies do report an increased risk. The issue cannot be finally settled until even larger studies on children conceived by intracytoplasmatic sperm injection are published.
大量生育诊所都在进行胞浆内单精子注射(ICSI);自1991年以来,已有数千名儿童通过这种方法受孕。胞浆内单精子注射与传统体外受精(IVF)不同,它是用玻璃微吸管将单个精子机械地注入成熟卵母细胞。人们担心胞浆内单精子注射是否会损害卵母细胞中的染色体和/或纺锤体装置,从而导致先天性异常风险增加。
我们回顾了有关通过胞浆内单精子注射受孕儿童先天性异常的文献。
尽管这些报告在方法上存在异质性,但大多数文章得出结论,与传统体外受精或正常受孕儿童相比,胞浆内单精子注射不会导致先天性异常风险在统计学上显著增加。然而,一些研究确实报告了风险增加。在发表关于通过胞浆内单精子注射受孕儿童的更大规模研究之前,这个问题无法最终解决。